The Centers for Medicare & Medicaid Services has selected 61 applicants for the Value in Opioid Use Disorder Treatment Demonstration, a four-year Medicare payment model beginning this month for selected health care providers who agree to participate.

Participants will test whether a new care management fee and performance-based incentive payment for OUD treatment services reduces hospitalizations and improves health outcomes for Medicare fee-for-service patients with OUDs, including those dually eligible for Medicaid. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorizes $10 million annually in fiscal years 2021-2024 to pay for the treatment services. 

Related News Articles

Headline
The Brigham Comprehensive Opioid Response and Education program and McLean Hospital of Belmont, Mass., on Sept. 21 at 12 p.m. ET will host a town hall virtual…
Blog
Post-acute care (PAC) providers continue to play a central role in COVID-19 response and recovery. In particular, providers in COVID-19 hotspots have been…
Blog
A new report from the Community Oncology Alliance (COA) once again tries to obfuscate the issue of sky-rocketing drug prices by choosing to blame hospitals…
Headline
The Centers for Medicare & Medicaid Services yesterday proposed repealing a final rule codifying how it defines “reasonable and necessary” coverage…
Headline
The Centers for Medicare & Medicaid Services Friday awarded four organizations an initial $2 million each to serve as lead organizations for the Community…
Headline
The National Institutes of Health yesterday released a study revealing a 38% increase in the opioid overdose death rate for non-Hispanic Black people in four…